Health Care: Drugs

Orexigen Therapeutics Inc (OREX: NASDAQ)

$6.1 -0.23 | -3.63%
12/22/14 - 11:51 AM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 3.43M 3.43M 4.40M 1.23M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 3.43M 3.43M 4.40M 1.23M
Selling, General, and Administrative Expenses 23.88M 19.99M 19.50M 24.50M
Research & Development 56.75M 73.68M 12.78M 28.13M
Operating Income before D & A (EBITDA) -77.20M -90.24M -27.88M -51.40M
Depreciation & Amortization 1.22M 813.00K 1.50M 1.79M
Interest Income 65.00K 147.00K 46.00K 124.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -78.36M -90.90M -29.34M -53.06M
Interest Expense 538.00K 2.00K 221.00K 644.00K
Pre-Tax Income -78.90M -90.91M -29.56M -53.71M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -77.67M -90.09M -28.06M -51.92M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -77.67M -90.09M -28.06M -51.92M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -77.67M -90.09M -28.06M -51.92M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-77.67M -90.09M -28.06M -51.92M
Preferred Dividends
Net Income Available To Common -77.67M -90.09M -28.06M -51.92M
Basic EPS from Continuing Ops. -0.80 -1.27 -0.58 -1.10
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.80 -1.27 -0.58 -1.10
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.80 -1.27 -0.58 -1.10
Basic Normalized Net Income/Share -0.80 -1.27 -0.58 -1.10
EPS fr Continuing Ops. -0.80 -1.27 -0.58 -1.10
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.80 -1.27 -0.58 -1.10
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.80 -1.27 -0.58 -1.10
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.80 -1.27 -0.58 -1.10
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with OREX

Latest OREX Headlines from TheStreet

More Financial News for OREX

Press Releases for OREX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter